Lv11
10 积分 2025-09-25 加入
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies
3小时前
待确认
Cracking the Code of Immunotherapy Resistance in SCLC: Molecular Insights and Emerging Solutions
3小时前
已完结
Undetectable pre‐radical cystectomy circulating tumour DNA status predicts improved oncological outcomes
1个月前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
1个月前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
1个月前
已完结
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
1个月前
已完结
Ensemble transformer-based multiple instance learning to predict pathological subtypes and tumor mutational burden from histopathological whole slide images of endometrial and colorectal cancer
2个月前
已完结
Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer
2个月前
已完结
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study
3个月前
已完结
Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
